BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24030487)

  • 1. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial.
    Ogura T; Imoto A; Okuda A; Fukunishi S; Higuchi K
    Dig Dis; 2019; 37(3):255-261. PubMed ID: 30654370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
    He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
    J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
    Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
    Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
    Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
    Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Use of Low Osmolality Contrast Medium Reduce the Frequency of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Comparative Study between Use of Low and High Osmolality Contrast Media.
    Nagashima K; Ijima M; Kimura K; Kurihara E; Tominaga K; Fukushi K; Kanamori A; Otake Y; Irisawa A
    Digestion; 2021; 102(2):283-288. PubMed ID: 31770751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
    Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
    World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of two types of contrast media used in endoscopic retrograde cholangiopancreatography: A retrospective study.
    Matsuura T; Hamaya Y; Onoue S; Tamura S; Ishida N; Yamade M; Tani S; Iwaizumi M; Osawa S; Furuta T; Sugimoto K
    PLoS One; 2023; 18(1):e0280279. PubMed ID: 36608042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin].
    Montaño Loza A; García Correa J; González Ojeda A; Fuentes Orozco C; Dávalos Cobián C; Rodríguez Lomelí X
    Rev Gastroenterol Mex; 2006; 71(3):262-8. PubMed ID: 17140047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia].
    Liu CG; Leng DY; Liu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):607-10. PubMed ID: 19852292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients.
    Mariani A; Giussani A; Di Leo M; Testoni S; Testoni PA
    Gastrointest Endosc; 2012 Feb; 75(2):339-46. PubMed ID: 22075192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.